国际医学
(000516)
| 流通市值：93.92亿 | | | 总市值：95.38亿 |
| 流通股本：22.05亿 | | | 总股本：22.39亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,032,048,577.68 | 969,398,246.51 | 4,074,514,927.55 | 2,995,437,323.47 |
| 营业总成本 | 2,143,314,801.25 | 1,046,750,589.27 | 4,523,904,141.74 | 3,379,382,067.18 |
| 其他经营收益 | | | | |
| 营业利润 | -109,090,561.09 | -71,163,831 | -400,439,519.31 | -360,502,200.22 |
| 利润总额 | -110,176,244.2 | -71,127,241.53 | -400,297,695.35 | -360,210,877.21 |
| 净利润 | -116,364,858.26 | -73,671,879.9 | -421,027,140.03 | -374,029,115.97 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -116,364,858.26 | -73,671,879.9 | -421,027,140.03 | -374,029,115.97 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 903,915,340.05 | 1,041,889,271.99 | 1,131,406,707.17 | 1,150,867,696.8 |
| 非流动资产: | | | | |
| 非流动资产合计 | 8,284,766,064.79 | 8,455,551,450.84 | 8,579,646,677.03 | 8,639,788,816.09 |
| 资产总计 | 9,188,681,404.84 | 9,497,440,722.83 | 9,711,053,384.2 | 9,790,656,512.89 |
| 流动负债: | | | | |
| 流动负债合计 | 4,078,370,810.25 | 4,217,033,371.74 | 4,452,623,490.1 | 4,229,596,306.02 |
| 非流动负债: | | | | |
| 非流动负债合计 | 2,219,403,135.06 | 2,346,806,913.2 | 2,251,157,576.31 | 2,506,789,865.02 |
| 负债合计 | 6,297,773,945.31 | 6,563,840,284.94 | 6,703,781,066.41 | 6,736,386,171.04 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,252,841,534.5 | 3,269,820,226.86 | 3,318,161,776.34 | 3,337,580,628.58 |
| 股东权益合计 | 2,890,907,459.53 | 2,933,600,437.89 | 3,007,272,317.79 | 3,054,270,341.85 |
| 负债和股东权益合计 | 9,188,681,404.84 | 9,497,440,722.83 | 9,711,053,384.2 | 9,790,656,512.89 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,108,185,473.58 | 1,026,418,902.81 | 4,319,228,091.84 | 3,200,253,779.93 |
| 经营活动现金流出小计 | 1,614,722,435.51 | 776,967,461.49 | 3,042,758,570.07 | 2,279,249,924.38 |
| 经营活动产生的现金流量净额 | 493,463,038.07 | 249,451,441.32 | 1,276,469,521.77 | 921,003,855.55 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 19,094,432 | 19,083,432 | 136,355,396.01 | 88,216,010.89 |
| 投资活动现金流出小计 | 115,092,950.15 | 58,324,330.78 | 263,467,565.06 | 235,376,144.3 |
| 投资活动产生的现金流量净额 | -95,998,518.15 | -39,240,898.78 | -127,112,169.05 | -147,160,133.41 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 519,850,000 | 344,350,000 | 493,010,000 | 266,310,000 |
| 筹资活动现金流出小计 | 1,151,681,404.31 | 600,865,577.66 | 1,801,794,328.32 | 1,345,642,955.84 |
| 筹资活动产生的现金流量净额 | -631,831,404.31 | -256,515,577.66 | -1,308,784,328.32 | -1,079,332,955.84 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -234,366,884.39 | -46,305,035.12 | -159,426,975.6 | -305,489,233.7 |
| 期末现金及现金等价物余额 | 154,768,143.39 | 342,829,992.66 | 389,135,027.78 | 243,072,769.68 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -234,366,884.39 | - | -159,426,975.6 | - |
最新报告期：2026-09-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 华冉,王在存,贺菊颖 | -0.06 | -0.05 | -0.03 | 2026-09-30 |
| 东海证券 | 杜永宏 | -0.10 | -0.06 | -0.02 | 2026-09-17 |